Pregnant with eczema? study tracks skin Cream's safety for baby
NCT ID NCT06259669
Summary
This study aims to understand if using ruxolitinib cream for mild to moderate eczema during pregnancy affects the baby's health. Researchers will compare pregnancy outcomes and infant health between women who used the cream and those who did not. The study is observational, meaning it tracks what happens in real life without assigning treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Syneos Health (remote site)
RECRUITINGMorrisville, North Carolina, 27560, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.